Sigilon Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q2 2023.
  • Sigilon Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2023 was $310K, a 42.9% decline year-over-year.
  • Sigilon Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2023 was $2.18M, a 6.72% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Interest Expense for 2022 was $2.29M, a 15.2% increase from 2021.
  • Sigilon Therapeutics, Inc. annual Interest Expense for 2021 was $1.99M, a 65.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2.18M $310K -$233K -42.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $2.41M $611K +$120K +24.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $2.29M $650K +$143K +28.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $2.15M $606K +$107K +21.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.04M $543K +$49K +9.92% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.99M $491K +$3K +0.62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.99M $507K +$2K +0.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $1.99M $499K +$206K +70.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.78M $494K +$298K +152% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.48M $488K +$280K +135% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.2M $505K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $293K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $196K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $208K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.